Futura Medical announce regulatory and commercial progress on erectile disfunction gel

Futura Medical PLC's (LON:FUM) James Barder talks to Proactive London's Katie Pilbeam about the announcement made today on the regulatory progress in the US.

Barder also hints upon significant commercial interest for its erectile dysfunction gel with talks ongoing with a growing number of potential partners.

Med3000 is an over-the-counter treatment and as a consequence would have huge commercial potential. Barder is confident the negotiations with the FDA will be satisfactorily and is planning for a Q1 confirmation.